Patrick Trucchio
Stock Analyst at HC Wainwright & Co.
(4.17)
# 506
Out of 5,033 analysts
387
Total ratings
44.07%
Success rate
17.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Patrick Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASMB Assembly Biosciences | Assumes: Buy | $50 | $30.75 | +62.60% | 1 | Aug 18, 2025 | |
| ALT Altimmune | Reiterates: Buy | $12 | $3.92 | +206.12% | 19 | Aug 13, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $500 → $570 | $485.26 | +17.46% | 27 | Aug 7, 2025 | |
| CMPS COMPASS Pathways | Maintains: Buy | $45 → $40 | $6.60 | +506.06% | 17 | Aug 4, 2025 | |
| ATAI Atai Life Sciences | Maintains: Buy | $10 → $15 | $6.43 | +133.46% | 20 | Jul 30, 2025 | |
| ANRO Alto Neuroscience | Reiterates: Buy | $10 | $11.30 | -11.50% | 2 | Jun 26, 2025 | |
| IVVD Invivyd | Reiterates: Buy | $5 | $1.90 | +163.85% | 19 | Jun 26, 2025 | |
| SGMO Sangamo Therapeutics | Reiterates: Buy | $10 | $0.66 | +1,414.00% | 26 | Jun 24, 2025 | |
| SLN Silence Therapeutics | Reiterates: Buy | $75 | $6.95 | +979.14% | 24 | Jun 13, 2025 | |
| IMCR Immunocore Holdings | Reiterates: Buy | $100 | $33.52 | +198.33% | 21 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $61.88 | +13.12% | 15 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.13 | +344.44% | 18 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $7.11 | +743.88% | 18 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $37.94 | +110.86% | 23 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $13.93 | +187.15% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $4.96 | +504.84% | 10 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $25.87 | +170.58% | 6 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $29.08 | +175.10% | 8 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $10 | $1.97 | +408.91% | 19 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.21 | +352.49% | 16 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $13.10 | +319.85% | 18 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $110 | $6.12 | +1,697.39% | 23 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $62.34 | +36.36% | 2 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $190 → $150 | $6.29 | +2,284.74% | 17 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $170 → $68 | $15.88 | +328.21% | 2 | Sep 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $260 → $340 | $185.13 | +83.65% | 1 | Aug 18, 2021 |
Assembly Biosciences
Aug 18, 2025
Assumes: Buy
Price Target: $50
Current: $30.75
Upside: +62.60%
Altimmune
Aug 13, 2025
Reiterates: Buy
Price Target: $12
Current: $3.92
Upside: +206.12%
Alnylam Pharmaceuticals
Aug 7, 2025
Maintains: Buy
Price Target: $500 → $570
Current: $485.26
Upside: +17.46%
COMPASS Pathways
Aug 4, 2025
Maintains: Buy
Price Target: $45 → $40
Current: $6.60
Upside: +506.06%
Atai Life Sciences
Jul 30, 2025
Maintains: Buy
Price Target: $10 → $15
Current: $6.43
Upside: +133.46%
Alto Neuroscience
Jun 26, 2025
Reiterates: Buy
Price Target: $10
Current: $11.30
Upside: -11.50%
Invivyd
Jun 26, 2025
Reiterates: Buy
Price Target: $5
Current: $1.90
Upside: +163.85%
Sangamo Therapeutics
Jun 24, 2025
Reiterates: Buy
Price Target: $10
Current: $0.66
Upside: +1,414.00%
Silence Therapeutics
Jun 13, 2025
Reiterates: Buy
Price Target: $75
Current: $6.95
Upside: +979.14%
Immunocore Holdings
Jun 2, 2025
Reiterates: Buy
Price Target: $100
Current: $33.52
Upside: +198.33%
May 29, 2025
Reiterates: Buy
Price Target: $70
Current: $61.88
Upside: +13.12%
May 21, 2025
Reiterates: Buy
Price Target: $5
Current: $1.13
Upside: +344.44%
May 21, 2025
Reiterates: Buy
Price Target: $60
Current: $7.11
Upside: +743.88%
May 20, 2025
Reiterates: Buy
Price Target: $80
Current: $37.94
Upside: +110.86%
May 9, 2025
Reiterates: Buy
Price Target: $40
Current: $13.93
Upside: +187.15%
Apr 8, 2025
Reiterates: Buy
Price Target: $30
Current: $4.96
Upside: +504.84%
Apr 8, 2025
Reiterates: Buy
Price Target: $70
Current: $25.87
Upside: +170.58%
Apr 7, 2025
Reiterates: Buy
Price Target: $80
Current: $29.08
Upside: +175.10%
Apr 1, 2025
Maintains: Buy
Price Target: $25 → $10
Current: $1.97
Upside: +408.91%
Mar 18, 2025
Reiterates: Buy
Price Target: $10
Current: $2.21
Upside: +352.49%
Mar 7, 2025
Reiterates: Buy
Price Target: $55
Current: $13.10
Upside: +319.85%
Feb 28, 2025
Reiterates: Buy
Price Target: $110
Current: $6.12
Upside: +1,697.39%
Feb 19, 2025
Reiterates: Buy
Price Target: $85
Current: $62.34
Upside: +36.36%
Feb 13, 2025
Maintains: Buy
Price Target: $190 → $150
Current: $6.29
Upside: +2,284.74%
Sep 23, 2022
Maintains: Buy
Price Target: $170 → $68
Current: $15.88
Upside: +328.21%
Aug 18, 2021
Maintains: Outperform
Price Target: $260 → $340
Current: $185.13
Upside: +83.65%